IPVS 2025 Workshops

IPVS 2025 workshops will focus on this year’s theme,“Research toward the Global Elimination of HPV-Related Diseases and Cancers.” The meeting promises to be a platform for the reporting of cutting-edge, international, HPV and animal papillomavirus research from different perspectives and participate in wider scientific discussions. Workshops organized by leading scientists and key opinion leaders in their fields will provide an opportunity for delegates to hear “state-of-the-art” developments in basic science, public health, and clinical science.

Workshops will be run by and have speakers who are worldwide leaders in the field. They will provide a unique forum for education and discussion.

Although workshops stand alone as an educational and scientific activity, they are designed to provide the necessary scientific background to follow the main Conference, where the latest knowledge in research will be presented. For junior scientists, the workshops will help them to be educated on both the basics and cutting-edge knowledge of papillomavirus biology, epidemiology, and prevention and control of papillomavirus infections and diseases.

A dedicated early careers track will also provide the opportunity for young scientists to showcase their work and make connections. The workshops will provide an overview to non-experts on all papillomavirus (PV)-related topics, from basic science to global health impact.

IPVS 2025 workshops will be a unique way to connect across the fields, and attendees will enjoy PV research from different perspectives and participate in wider scientific discussions.

IPVS Workshops

The IPVS Workshop lectures are educational lectures, designed to prepare attendees to understand the new science that will be presented in the Scientific Sessions.

Thursday, October 23, 2025

Click on the sections below to learn more about the workshops. Please note the information might be subject to change.

INTERDISCIPLINARY WORKSHOPS

09:00-10:30

Interdisciplinary Workshop

Public Health Chair: Ann Burchell (Canada)

Clinical Science Chair: Barbara Moscicki (USA)

Basic Science Chair: Karl Munger (USA)

 

Discussion Panel led by co-chairs.

 

 

BASIC SCIENCE TRACK

11:00 – 12:30

Basic Science Workshop 1: HPV and Host Transcriptional Dynamics: Mechanisms and Biomarkers 

Chair: TBA

Chairs’ introduction

HPV manipulates host cell promoter-enhancer interactions to reprogram host transcription

 

Cellular transcription factor as prognostic biomarkers and drug targets of HPV carcinogenesis

 

Expression and localization of LCR-associated transcription factors differs between HPV-positive and negative HNSCC cells

 

TBX3, HPV and cervical cancer

 

14:30 – 16:00

Basic Science Workshop 2: DNA damage replication and carcinogenic progression 

Chair: TBA
Chair: 

Chair Introduction

Epigenetic regulation of the HPV life cycle by the DNA Damage Response

 

DNA damage and Papillomavirus genome replication 

 

Genomic signatures of DNA repair in HPV-associated tumor genomes

 

Beta HPVs and DNA repair

 

16:10 – 17:10

Basic Science Workshop 3: Bioinformatics Strategies for Uncovering HPV Biomarkers and Carcinogenic Pathways 

Chair: TBA

Chair Introduction

Content for session TBA

 

 

 

 

CLINICAL SCIENCE TRACK

11:00-12:30

Clinical Science Workshop 1: The 2 pillars of cervical cancer elimination: screening and management of cervical (pre)cancer 

Chair: TBD

Chair: 

Natural history of HPV in women, men and those living with immunosuppression   

 

Risk-based referral strategies in cervical cancer screening, (topics may include, partial vs full genotyping, dual staining, expedited treatment, VIA and “see and treat” approaches, AI, methylation

 

Ablative or excisional treatment of cervical precancerous lesions in LIC and HIC. 

 

What’s on the horizon: non-surgical approaches for HPV or HPV associated lesions: what works and what doesn’t

 

14:30-16:00

Clinical Science Workshop 2: Anal cancer secondary prevention. The cervical cancer paradigm is just the beginning 

Chair: TBD

Pathogenesis of anal cancer with relevance to prevention 

 

New guidelines and what to do with them (comparison of different countries models)

 

HRA implementation and challenges: when things go wrong! 

 

Treatment modalities (surgical and non surgical) for anal HSIL

 

Discussion and Q&A

16:10-17:10

Clinical Science Workshop 3: Clinical debates for HPV-related diseases 

Chair: TBD

1.Non 16/18 CIN2: To treat or not to treat?

  •  5 min Yes to treat: TBA
  •  5 min Not to treat: TBA
  • 5 min discussion.

2. Post-cervical conization HPV vaccination.

  •  5 min Yes: TBA
  •  5 min No: TBA
  • 5 min discussion.

 3. Anal cancer screening: HPV testing (yes vs no) .

  • 5 min Yes: TBA
  • 5 min No: TBA
  • 5 min discussion

4. Primary HPV screening among 21–29-year-olds

  • 5 min yes use HPV screening in this age group: TBA
  • 5 min No, do not use PHS: TBA
  • 5 min discussion

PUBLIC HEALTH, EPIDEMIOLOGY AND IMPLEMENTATION SCIENCE TRACK

11:00 – 12:30

Public Health Workshop 1: The epidemiology of HPV and related diseases: Burden and opportunities for prevention

Chair: TBA

Chair:TBA

Chair introduction to PH Workshop

Epidemiology of cervical HPV infection and disease

 

Epidemiology of vaginal and vulvar HPV infection and disease

 

Epidemiology of penile HPV infection and disease

Anna Giuliano

Epidemiology of anal HPV infection and disease

 

Panel Discussion with Q&A

14:30 – 16:00

Public Health Workshop 2: Primary & secondary prevention of HPV-related diseases: What are the current approaches?

Chair:

Chair: 

Evolution of HPV vaccination strategies and programs over time and variability across regions

 

Real-world effectiveness of HPV vaccination among people living with HIV

Ruanne Barnabas

Cervical cancer screening: *The established screening approach*

Chemtai Mungo

Anal cancer screening: *New screening practice in early stages of implementation*

 

Panel Discussion and Q&A

16:10 – 17:10

Public Health Workshop 3: Implementation strategies to support HPV prevention: how do we get there?

Chair:

Chair:

Introduction by Chairs

Implementation of vaccine policy

 

Mathematical modelling to advise HPV prevention

Marc Brisson

Future-forward HPV prevention policy in the region

 

Panel Discussion with Q&A

Please note that the workshops for IPVS 2025 are included in the conference fee. No additional fee or pre-registration is required. 

Subscribe Visit 2024 website IPVS Education Center Membership